 WILMINGTON, Del., Feb. 11, 2022 GLOBE NEWSWIRE -- Prelude Therapeutics Inc. NASDAQ: PRLD, a clinical-stage precision oncology company, today announced that Kris Vaddi, PhD, Chief Executive Officer, will present virtually at the 11th Annual SVB Leerink Global Healthcare Conference on Friday, February 18 at 1:40 p.m. ET. 